Pfeuffer S - Search Results

1

Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells.

Ruck T, Pfeuffer S, Schulte-Mecklenbeck A, Gross CC, Lindner M, Metze D, Ehrchen J, Sondermann W, Pul R, Kleinschnitz C, Wiendl H, Meuth SG, Klotz L. Ruck T, et al. Among authors: pfeuffer s. Neurology. 2018 Dec 11;91(24):e2233-e2237. doi: 10.1212/WNL.0000000000006648. Epub 2018 Nov 7. Neurology. 2018. PMID: 30404783 Free PMC article.

2

ALAIN01--Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential.

Ruck T, Afzali AM, Lukat KF, Eveslage M, Gross CC, Pfeuffer S, Bittner S, Klotz L, Melzer N, Wiendl H, Meuth SG. Ruck T, et al. Among authors: pfeuffer s. BMC Neurol. 2016 Mar 10;16:34. doi: 10.1186/s12883-016-0556-9. BMC Neurol. 2016. PMID: 26966029 Free PMC article. Clinical Trial.

3

Simultaneous early-onset immune thrombocytopenia and autoimmune thyroid disease following alemtuzumab treatment in relapsing-remitting multiple sclerosis.

Obermann M, Ruck T, Pfeuffer S, Baum J, Wiendl H, Meuth SG. Obermann M, et al. Among authors: pfeuffer s. Mult Scler. 2016 Aug;22(9):1235-41. doi: 10.1177/1352458516638558. Epub 2016 Mar 15. Mult Scler. 2016. PMID: 26980848 Review.

4

Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.

Pfeuffer S, Ruck T, Kleinschnitz C, Wiendl H, Meuth SG. Pfeuffer S, et al. Expert Rev Neurother. 2016 Jun;16(6):689-700. doi: 10.1080/14737175.2016.1176531. Epub 2016 Apr 25. Expert Rev Neurother. 2016. PMID: 27058174 Review.

5

Acute cholecystitis during treatment with alemtuzumab in 3 patients with RRMS.

Pfeuffer S, Beuker C, Ruck T, Lenze F, Wiendl H, Melzer N, Meuth SG. Pfeuffer S, et al. Neurology. 2016 Nov 29;87(22):2380-2381. doi: 10.1212/WNL.0000000000003379. Epub 2016 Oct 28. Neurology. 2016. PMID: 27794114 No abstract available.

6

An Enigmatic Case of Acute Mercury Poisoning: Clinical, Immunological Findings and Platelet Function.

Kleffner I, Eichler S, Ruck T, Schüngel L, Pfeuffer S, Polzer P, Dittrich R, Dziewas R, Gross CC, Göbel K, Wiendl H, Kehrel BE, Meuth SG. Kleffner I, et al. Among authors: pfeuffer s. Front Neurol. 2017 Sep 28;8:517. doi: 10.3389/fneur.2017.00517. eCollection 2017. Front Neurol. 2017. PMID: 29033890 Free PMC article.

7

Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational Study.

Riepl E, Pfeuffer S, Ruck T, Lohmann H, Wiendl H, Meuth SG, Johnen A. Riepl E, et al. Among authors: pfeuffer s. Front Neurol. 2018 Jan 16;8:730. doi: 10.3389/fneur.2017.00730. eCollection 2017. Front Neurol. 2018. PMID: 29387035 Free PMC article.

8

Sarcoidosis following alemtuzumab treatment: Autoimmunity mediated by T cells and interferon-γ.

Pfeuffer S. Pfeuffer S. Mult Scler. 2018 Nov;24(13):1783-1784. doi: 10.1177/1352458518804124. Epub 2018 Oct 11. Mult Scler. 2018. PMID: 30307361 Review. No abstract available.

9

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation.

Pfeuffer S, Schmidt R, Straeten FA, Pul R, Kleinschnitz C, Wieshuber M, Lee DH, Linker RA, Doerck S, Straeten V, Windhagen S, Pawlitzki M, Aufenberg C, Lang M, Eienbroeker C, Tackenberg B, Limmroth V, Wildemann B, Haas J, Klotz L, Wiendl H, Ruck T, Meuth SG. Pfeuffer S, et al. J Neurol. 2019 Jan;266(1):165-173. doi: 10.1007/s00415-018-9117-z. Epub 2018 Nov 16. J Neurol. 2019. PMID: 30446966

10

Isolation of Primary Murine Skeletal Muscle Microvascular Endothelial Cells.

Müntefering T, Michels APE, Pfeuffer S, Meuth SG, Ruck T. Müntefering T, et al. Among authors: pfeuffer s. J Vis Exp. 2019 Mar 6;(145). doi: 10.3791/58901. J Vis Exp. 2019. PMID: 30907887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page